4th Quarter - Report — AMERICAN CLINICAL LABORATORY ASSN for AMERICAN CLINICAL LABORATORY ASSN (2010)

Firm

AMERICAN CLINICAL LABORATORY ASSN

Client

AMERICAN CLINICAL LABORATORY ASSN

Income

—

Expenses

$188,000

Expense method

C: businesses, Internal Revenue Code section 162(e)

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

PL 111-148: health reform law implementation issues including application of medical device tax to laboratory tests; HR 4213/S. 3551, American Jobs and Closing Tax Loopholes Act of 2010: health care provisions including physician payment; HR 5440 Genomics and Personalized Medicine ACt of 2010; FDA oversight of laboratory developed tests; the Technical Component for physician pathology services; and the the Centers for Medicare and Medicaid Services physician signature issue;

Lobbyist	Covered position, as disclosed
JASON DUBOIS	Vice President, Government Relations
JO ANNE GLISSON	Senior Vice President
CHARLENE MACDONALD	Vice President, Government Relations
ALAN MERTZ	President
DAVID ALAN MONGILLO	Vice President, Policy and Medical Affairs

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); Treasury, Dept of; Food & Drug Administration (FDA)

Bills named: H.R. 4213 (111th), H.R. 5440 (111th), S. 3551 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.